{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T20:48:17Z","timestamp":1761252497104,"version":"3.33.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.pbb.2007.03.019","type":"journal-article","created":{"date-parts":[[2007,4,7]],"date-time":"2007-04-07T11:16:30Z","timestamp":1175944590000},"page":"48-55","source":"Crossref","is-referenced-by-count":20,"title":["Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice"],"prefix":"10.1016","volume":"87","author":[{"given":"Tomohiro","family":"Tatsuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobue","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kitanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiko","family":"Takemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2007.03.019_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2005.00355.x","article-title":"Topiramate prevents ecstasy consumption: a case report","volume":"19","author":"Akhondzadeh","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2007.03.019_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-859X-4-5","article-title":"Review of the use of topiramate for treatment of psychiatric disorders","volume":"4","author":"Arnone","year":"2005","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.pbb.2007.03.019_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00001756-200401190-00040","article-title":"Topiramate attenuates withdrawal signs after chronic intermittent ethanol in rats","volume":"15","author":"Cagetti","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2007.03.019_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03190614","article-title":"Metabolism and excretion of the antiepileptic\/antimigraine drug, topiramate in animals and humans","volume":"30","author":"Caldwell","year":"2005","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pbb.2007.03.019_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0741-8329(02)00199-4","article-title":"GABAA receptor modulation of the rewarding and aversive effects of ethanol","volume":"26","author":"Chester","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.pbb.2007.03.019_bib6","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2007.03.019_bib7","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1528-1157.2000.tb06047.x","article-title":"Topiramate as an inhibitor of carbonic anhydrase isoenzymes","volume":"41","author":"Dodgson","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2007.03.019_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/01.ALC.0000150014.79657.64","article-title":"Effects of topiramate on ethanol and saccharin consumption and preferences in C57BL\/6 mice","volume":"29","author":"Gabriel","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2007.03.019_bib9","series-title":"Substance abuse: a comprehensive textbook","first-page":"48","article-title":"Brain-reward mechanisms","author":"Gardner","year":"2004"},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2007.03.019_bib10","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.2000.tb02164.x","article-title":"Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons","volume":"41","author":"Gibbs","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2007.03.019_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1530-0277.2006.00091.x","article-title":"Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA\/2J or C57BL\/6J mice","volume":"30","author":"Gremel","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.pbb.2007.03.019_bib12","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1523\/JNEUROSCI.23-18-07069.2003","article-title":"Selective antagonism of Glu5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons","volume":"23","author":"Gryder","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2007.03.019_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0091-3057(99)00263-4","article-title":"The role of benzodiazepine in the acquisition and expression of behavioral sensitization to methamphetamine","volume":"65","author":"Ito","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2007.03.019_bib14","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomized controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2007.03.019_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","article-title":"A pilot trial of topiramate for the treatment of cocaine dependence","volume":"75","author":"Kampman","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2007.03.019_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2165\/00003495-200363040-00001","article-title":"Vaccines against drugs of abuse: a viable treatment option?","volume":"63","author":"Kantak","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.pbb.2007.03.019_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-2999(03)02015-6","article-title":"Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration","volume":"474","author":"Kitanaka","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2007.03.019_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pbb.2005.10.004","article-title":"2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice","volume":"82","author":"Kitanaka","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2007.03.019_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/117739280600100001","article-title":"Modification of monoaminergic activity by MAO inhibitors influences methamphetamine actions","volume":"1","author":"Kitanaka","year":"2006","journal-title":"Drug Target Insights"},{"key":"10.1016\/j.pbb.2007.03.019_bib20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11064-006-9081-3","article-title":"Methamphetamine reward in mice as assessed by conditioned place preference test with Supermex\u00ae sensors: effect of subchronic clorgyline pretreatment","volume":"31","author":"Kitanaka","year":"2006","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pbb.2007.03.019_bib21","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/jm00388a023","article-title":"Anticonvulsant O-alkyl sulfamates: 2,3:4,5-bis-O-(1-methylethylidiene)-\u03b2-d-fructopyranose sulfamate and related compounds","volume":"30","author":"Maryanoff","year":"1987","journal-title":"J Med Chem"},{"key":"10.1016\/j.pbb.2007.03.019_bib22","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0165-0173(98)00052-6","article-title":"An update on GABAA receptors","volume":"29","author":"Mehta","year":"1999","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2007.03.019_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00001756-200207020-00007","article-title":"Baclofen decreases methamphetamine self-administration in rats","volume":"13","author":"Ranaldi","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2007.03.019_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal model of amphetamine psychosis","volume":"11","author":"Robinson","year":"1986","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2007.03.019_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/syn.10000","article-title":"Topiramate selectively attenuates nicotine-induced increase in monoamine release","volume":"42","author":"Schiffer","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2007.03.019_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"32","author":"Seiden","year":"1993","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pbb.2007.03.019_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1146\/annurev.ne.18.030195.002335","article-title":"Molecular mechanisms of drug reinforcement and addiction","volume":"18","author":"Self","year":"1995","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pbb.2007.03.019_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1528-1157.1994.tb02459.x","article-title":"Topiramate: preclinical evaluation of structurally novel anticonvulsant","volume":"35","author":"Shank","year":"1994","journal-title":"Epilepsia"},{"issue":"Suppl.1","key":"10.1016\/j.pbb.2007.03.019_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2007.03.019_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00023210-200519010-00002","article-title":"Novel approaches to the treatments of cocaine addiction","volume":"19","author":"Sofuoglu","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2007.03.019_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00213-005-0296-9","article-title":"Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers","volume":"184","author":"Sofuoglu","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.pbb.2007.03.019_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2007.03.019_bib33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11064-005-8390-2","article-title":"Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats","volume":"30","author":"Tatsuta","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pbb.2007.03.019_bib34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(24)38047-4","article-title":"Inhibition of transient and persistent Na+-current fractions by the new anticonvulsant topiramate","volume":"288","author":"Taverna","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2007.03.019_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-1211(97)00045-4","article-title":"Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold","volume":"28","author":"White","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pbb.2007.03.019_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0896-6273(02)00965-0","article-title":"Brain reward circuitry: insights from unsensed incentives","volume":"36","author":"Wise","year":"2002","journal-title":"Neuron"},{"issue":"Suppl.1","key":"10.1016\/j.pbb.2007.03.019_bib37","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/j.1528-1157.2000.tb02173.x","article-title":"Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate","volume":"41","author":"Zhang","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2007.03.019_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(97)00543-0","article-title":"Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells","volume":"231","author":"Zona","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2007.03.019_bib39","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1358\/dot.2004.40.7.850478","article-title":"Anticonvulsant drug in the treatment of substance withdrawal","volume":"40","author":"Zullino","year":"2004","journal-title":"Drugs of Today"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305707001219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305707001219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T17:16:01Z","timestamp":1736961361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305707001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0091305707001219"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2007.03.019","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}